Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Ottawa

$17,500.00

Investigating the role of Gastrin-Releasing Peptide in reconsolidation and extinction of fear-memory in rats: Implications for Post-Traumatic Stress Disorder.

FY 2013-14

Summary
Fear-memory related disorders are a pervasive and persistent form of mental illness; these include disorders such as Post-Traumatic Stress Disorder (PTSD) and Phobias (whereby a strong learned fear association that has been acquired through experience leads to significant distress in daily life, as well as possible deficits in day-to-day functioning). However, disorders like PTSD have remained particularly difficult to treat. Currently, treatments often rely on strategies such as systematic desensitization to extinguish learned fear associations. Research has shown, however, that extinguished fear memories often resurface over time. In addition, even if they do not reappear naturally over time, any re-exposure to the stimulus that caused the fear association can lead to the recurrence of symptoms. In recent years, research has uncovered processes relating to emotional memory that may shed light on new treatment avenues for disorders such as PTSD. Research findings suggest that when memories are recalled, they are returned to an unstable state from which they must be reconsolidated if they are to be maintained. Further findings suggest that pharmacological treatment may block the reconsolidation of re-activated fear memories. This process (reconsolidation blockade) effectively reduces the strength of learned fear-responses. Extinction refers to the process whereby new learning inhibits old learning – however, old learning is not necessarily replaced, and may reemerge. Learned fear-responses that are targeted by reconsolidation blockade, in contrast to extinction, do not tend to resurface. With regards to studying reconsolidation and extinction, animal models may help to develop new potential pharmacotherapies for the treatment of PTSD. Gastrin releasing peptide (the mammalian counterpart of the amphibian peptide Bombesin) has been increasingly implicated in regulating normal brain function as well as in the pathogenesis of psychiatric and/or neurodevelopmental disorders. Gastrin releasing peptide Receptor (GRPR) mRNA is highly expressed in the lateral nucleus of the amygdala, a key brain region implicated in acquired fear-memory associations. Previous findings have shown that application of GRP stimulates interneuron GRPRs to enhance inhibition of amygdalar principal neurons; this may inhibit fear-memory formation (and therefore may present a novel approach for blocking the re-consolidation of established fear-memories). The objective of the proposed research is to explore the effects of GRP on fear-memory processes. Using animal-models, we will examine the differential behavioural effects of GRP administration on learned fear in two paradigms (extinction and reconsolidation blockade). We will also focus on neurochemical and mRNA expression changes at brain sites relevant to learned fear. It is predicted that this research will yield relevant models of novel pharmaceutical treatments for PTSD that may be applied in the future (in translational studies) as possible treatment avenues for humans with PTSD. It will also shed light on the brain mechanisms relevant to learned fear, and will help further our understanding of the causes of fear-memory related disorders, potential treatments, and prevention of the development of PTSD.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
311690
Name
Murkar Anthony
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the role of Gastrin-Releasing Peptide in reconsolidation and extinction of fear-memory in rats: Implications for Post-Traumatic Stress Disorder.
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Extinction; Gastrin Releasing Peptide; Memory; Neuropharmacology; Post-Traumatic Stress Disorder; Reconsolidation
Abstract
Fear-memory related disorders are a pervasive and persistent form of mental illness; these include disorders such as Post-Traumatic Stress Disorder (PTSD) and Phobias (whereby a strong learned fear association that has been acquired through experience leads to significant distress in daily life, as well as possible deficits in day-to-day functioning). However, disorders like PTSD have remained particularly difficult to treat. Currently, treatments often rely on strategies such as systematic desensitization to extinguish learned fear associations. Research has shown, however, that extinguished fear memories often resurface over time. In addition, even if they do not reappear naturally over time, any re-exposure to the stimulus that caused the fear association can lead to the recurrence of symptoms. In recent years, research has uncovered processes relating to emotional memory that may shed light on new treatment avenues for disorders such as PTSD. Research findings suggest that when memories are recalled, they are returned to an unstable state from which they must be reconsolidated if they are to be maintained. Further findings suggest that pharmacological treatment may block the reconsolidation of re-activated fear memories. This process (reconsolidation blockade) effectively reduces the strength of learned fear-responses. Extinction refers to the process whereby new learning inhibits old learning – however, old learning is not necessarily replaced, and may reemerge. Learned fear-responses that are targeted by reconsolidation blockade, in contrast to extinction, do not tend to resurface. With regards to studying reconsolidation and extinction, animal models may help to develop new potential pharmacotherapies for the treatment of PTSD. Gastrin releasing peptide (the mammalian counterpart of the amphibian peptide Bombesin) has been increasingly implicated in regulating normal brain function as well as in the pathogenesis of psychiatric and/or neurodevelopmental disorders. Gastrin releasing peptide Receptor (GRPR) mRNA is highly expressed in the lateral nucleus of the amygdala, a key brain region implicated in acquired fear-memory associations. Previous findings have shown that application of GRP stimulates interneuron GRPRs to enhance inhibition of amygdalar principal neurons; this may inhibit fear-memory formation (and therefore may present a novel approach for blocking the re-consolidation of established fear-memories). The objective of the proposed research is to explore the effects of GRP on fear-memory processes. Using animal-models, we will examine the differential behavioural effects of GRP administration on learned fear in two paradigms (extinction and reconsolidation blockade). We will also focus on neurochemical and mRNA expression changes at brain sites relevant to learned fear. It is predicted that this research will yield relevant models of novel pharmaceutical treatments for PTSD that may be applied in the future (in translational studies) as possible treatment avenues for humans with PTSD. It will also shed light on the brain mechanisms relevant to learned fear, and will help further our understanding of the causes of fear-memory related disorders, potential treatments, and prevention of the development of PTSD.
Competitiondate
201312
Approvedterm2
1 yr 0 mth
Pinamesdelim
Murkar, Anthony
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~